APA (7th ed.) Citation

Karateev, D. E., Mazurov, V. I., Zonova, E. V., Nesmeyanova, O. B., Plaksina, T. V., Krechikova, D. G., . . . Usacheva, U. V. (2017). Comparative efficacy and safety of infliximab biosimilar (BCD-055) and innovator infliximab in patients with ankylosing spondylitis (results of international, multiple-center, double-blind phase I and phase III clinical studies). IMA-PRESS LLC.

Chicago Style (17th ed.) Citation

Karateev, D. E., et al. Comparative Efficacy and Safety of Infliximab Biosimilar (BCD-055) and Innovator Infliximab in Patients with Ankylosing Spondylitis (results of International, Multiple-center, Double-blind Phase I and Phase III Clinical Studies). IMA-PRESS LLC, 2017.

MLA (9th ed.) Citation

Karateev, D. E., et al. Comparative Efficacy and Safety of Infliximab Biosimilar (BCD-055) and Innovator Infliximab in Patients with Ankylosing Spondylitis (results of International, Multiple-center, Double-blind Phase I and Phase III Clinical Studies). IMA-PRESS LLC, 2017.